Corrigendum to CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/m-TOR pathway in vitro and in vivo: [Urol Oncol. 2018 Jun;36(6):312.e1-312.e8. / URO-D-17-00654R1].

Urol Oncol

Department of Urology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address:

Published: December 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urolonc.2022.09.005	DOI Listing

Publication Analysis

corrigendum suppresses

suppresses prostate

prostate cancer

cancer cell

cell growth

growth directly

directly targeting

targeting lkb1/ampk/m-tor

lkb1/ampk/m-tor pathway

pathway vitro

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!